Skip to main contentA logo with &quat;the muse&quat; in dark blue text.

Principal Scientist, Pharmacokinetics and Pharmacometrics

AT Johnson & Johnson
Johnson & Johnson

Principal Scientist, Pharmacokinetics and Pharmacometrics

Spring House, PA

Johnson & Johnson Innovative Medicine R&D is recruiting for a Principal Scientist, Clinical Pharmacokinetics and Pharmacometrics. The preferred location for this position is Spring House, PA. Alternate locations are Titusville, NJ or Raritan, NJ.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/

Want more jobs like this?

Get jobs delivered to your inbox every week.

Select a location
By signing up, you agree to our Terms of Service & Privacy Policy.


For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world's most pressing healthcare challenges.

We know that the success of our business - and our ability to deliver meaningful solutions - depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson & Johnson, we all belong.

The Principal Scientist role within Clinical Pharmacology and Pharmacometrics (CPP) will apply and promote clinical pharmacology knowledge, including the design of clinical pharmacology studies or clinical pharmacology component of clinical studies, pharmacokinetics/pharmacodynamics analyses and reporting, and application of principles of model-informed drug development (MIDD) within a program, with guidance from senior CPP leaders. With oversight, the Principal Scientist CPP will function as CPP Leader on the Compound Development Teams (CDT) working in collaboration with various stakeholders within the team and within Quantitative Sciences (e.g., Statistics, Pharmacometrics) and execute the day-to-day operations for the clinical pharmacology aspects of the assigned programs. Programs can be across all stages of drug development ranging from pre-New Molecular Entity (NME) declaration through Post-Marketing support.

Principal Responsibilities:

  • Contribute to overall compound development strategy via application of quantitative methods to integrate knowledge of nonclinical data (e.g., metabolism, BCS classification, pharmacology, safety), Pharmacokinetics (PK), Pharmacodynamics (PD) (e.g., biomarker, efficacy, and/or safety), patient characteristics, disease states, competitive landscape, and drug interactions to influence go/no go decisions, support patient sub-population, dose and dosage regimen selection, and optimize study designs throughout drug development. Translate quantitative knowledge into strategic opportunities to drive development along the model-informed drug development principles.
  • Plan and perform appropriate analysis (e.g., non-compartmental, population and/or modeling and simulation analysis of PK and/or PD data) of preclinical-clinical translation, dose/exposure-response relationships, to guide dose regimen and optimize study design.
  • Summarize and provide interpretation of results of PK and PK/PD analyses with respect to their impact on a development program and clinical use.
  • Design and execute scientifically robust and efficient clinical pharmacology strategies for development candidates.
  • Carries out functional responsibilities in accordance to applicable Standard Operating Procedures (SOPs), regulatory requirements and Johnson & Johnson Credo principles.
  • Plan and conduct PK and PK/PD analyses, provide independent Quality Control (QC), and report results in appropriate format (e.g., team presentations, memo, clinical study report).
  • Design Phase I clinical pharmacology studies and clinical pharmacology components of clinical studies.
  • Manage operational elements of CPP studies.
  • Perform literature searches and summarize the findings.
  • Contribute to preparation of Investigator's Brochure (IB), Investigational New Drugs (INDs), briefing books, submission package, and other regulatory documents as applicable to support clinical studies and/or programs.
  • Expand knowledge of clinical pharmacology, model informed drug development, analysis methodology and overall drug development process, including regulatory guidance, and methods in modeling and simulation by engaging with the scientific community (e.g., publishing, presenting at meetings, participating in special interest groups within professional societies, etc.) and internalize key learnings back to Janssen.
  • Work effectively in matrix environment, managing CP deliverables in accordance with timelines and overall project goals.
  • Apply appropriate regulatory (e.g., FDA, EMEA, ICH, etc.) guidelines in the design of clinical development plans and studies.
  • Apply relevant technical trainings/learnings to daily responsibilities, with focus of opportunistic deliver of value/impact.


Qualifications

  • A minimum of a Master's or PharmD degree in Pharmaceutical Sciences, Clinical Pharmacology, Biomedical Engineering, or related Biological Sciences discipline is required. Ph.D. in Pharmaceutical Sciences, Clinical Pharmacology, Biomedical Engineering, or related Biological Sciences discipline is preferred.
  • A minimum of 3 years of relevant experience with a Master's or PharmD degree or a minimum of 2 years of relevant experience (including postdoctoral studies) with a Ph.D. is required.
  • Advanced understanding of PK, PD, PK/PD, and/or Translational Medicine is required.
  • Understanding of advanced analysis methods (e.g., population analysis, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP)) and modeling tools (e.g., NONMEM, R, Gastroplus, Simcyp, Winnonlin, Matlab) is required.
  • Understanding of overall process of drug development including model informed drug development (MIDD) and the overall pharmaceutical R&D process is required.
  • Working knowledge of U.S., European, and Asian (including BRIC countries (Brazil, Russia, India, China)) regulatory requirements and guidelines is preferred.
  • Established level of expertise and scientific reputation through publications and/or presentations is preferred.
  • Must have excellent oral and written communication skills.
  • Must be a self-motivated team player who excels in a collaborative, multi-disciplinary team environment.
  • The ability to interpret PK and PKPD results and prepare presentations to communicate findings effectively is required.
  • The ability to interact and collaborate effectively in matrix environment is required.

The anticipated base pay range for this position in all other U.S. locations is $115,000 to $197,800.

The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation's performance over a calendar/ performance year. Bonuses are awarded at the Company's discretion on an individual basis.

Employees and/or eligible dependents may be eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance.

Employees may be eligible to participate in the Company's consolidated retirement plan (pension) and savings plan (401(k)).

Employees are eligible for the following time off benefits:

  • Vacation - up to 120 hours per calendar year
  • Sick time - up to 40 hours per calendar year; for employees who reside in the State of Washington - up to 56 hours per calendar year
  • Holiday pay, including Floating Holidays - up to 13 days per calendar year
  • Work, Personal and Family Time - up to 40 hours per calendar year

For additional general information on company benefits, please go to: https://www.careers.jnj.com/employee-benefits

The compensation and benefits information set forth in this posting applies to candidates hired in the United States. Candidates hired outside the United States will be eligible for compensation and benefits in accordance with their local market.

This job posting is anticipated to close on January 27, 2024. The Company may however extend this time-period, in which case the posting will remain available on https://www.careers.jnj.com to accept additional applications.

Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

Client-provided location(s): Spring House, PA, USA; Titusville, Hopewell Township, NJ 08560, USA; Raritan, NJ, USA
Job ID: Johnson&Johnson-2406228700W
Employment Type: Other